GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PHAT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Phathom Pharmaceuticals, Inc. stock price on Friday moving 10.89% between high and low
(Updated on Apr 19, 2024)

Sell candidate since Apr 17, 2024 Loss -8.47% PDF

The Phathom Pharmaceuticals, Inc. stock price fell by -5.38% on the last day (Friday, 19th Apr 2024) from $9.48 to $8.97. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 10.89% from a day low at $8.91 to a day high of $9.88. The price has fallen in 7 of the last 10 days and is down by -18.68% for this period. Volume has increased on the last day by 173 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 587 thousand shares were bought and sold for approximately $5.26 million.

Given the current short-term trend, the stock is expected to rise 46.47% during the next 3 months and, with a 90% probability hold a price between $13.14 and $18.40 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PHAT Signals & Forecast

There are few to no technical positive signals at the moment. The Phathom Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $9.84 and $9.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -25.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Phathom Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.85 and $7.23. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Phathom Pharmaceuticals, Inc. finds support just below today's level at $7.85. If this is broken, then the next support from accumulated volume will be at $7.23 and $7.08.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.97 between high and low, or 10.89%. For the last week, the stock has had daily average volatility of 6.23%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PHAT) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Phathom Pharmaceuticals, Inc. to open at $9.25, and during the day (based on 14 day Average True Range), to move between $8.14 and $9.80, which gives a possible trading interval of +/-$0.83 (+/-9.28%) up or down from last closing price. If Phathom Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 18.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.29 (3.57%) than the support at $7.85 (12.49%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Phathom Pharmaceuticals, Inc. stock A Buy?

The Phathom Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Phathom Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.227 Sell Candidate Unchanged

Predicted Opening Price for Phathom Pharmaceuticals, Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$9.25 ( 3.16%) $8.97

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PHAT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.22 13.97 %
R2 9.85 9.84 %
R1 9.62 7.29 %
Current price: 8.97
Support S1 8.88 -0.97 %
S2 8.65 -3.52 %
S3 8.28 -7.66 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.78 20.18 %
R2 10.47 16.72 %
R1 9.29 3.57 %
Current price 8.97
Support S1 7.85 -12.49%
S2 7.23 -19.40%
S3 7.08 -21.07%

FAQ

What is the symbol for Phathom Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Phathom Pharmaceuticals, Inc. is PHAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Phathom Pharmaceuticals, Inc. Stock?
The Phathom Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Phathom Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Phathom Pharmaceuticals, Inc. Stock?
Phathom Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Phathom Pharmaceuticals, Inc. Stock.

What's the current price of Phathom Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Phathom Pharmaceuticals, Inc. (PHAT) share was $8.97.

What is the 52-week high and low for Phathom Pharmaceuticals, Inc. Stock?
The 52-week high for Phathom Pharmaceuticals, Inc. Stock is $17.00 and the 52-week low is $6.07.

What is the market capitalization of Phathom Pharmaceuticals, Inc. Stock?
As of the 2024-04-19, the market capitalization of Phathom Pharmaceuticals, Inc. is 524.542M.

When is the next earnings date for Phathom Pharmaceuticals, Inc.?
The upcoming earnings date for Phathom Pharmaceuticals, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT